Literature DB >> 8139053

A soluble form of a receptor for subgroup A avian leukosis and sarcoma viruses (ALSV-A) blocks infection and binds directly to ALSV-A.

L Connolly1, K Zingler, J A Young.   

Abstract

A receptor that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses (ALSV-A) has been described (P. Bates, J. A. T. Young, and H. E. Varmus, Cell 74:1043-1051, 1993). A soluble form of the receptor was generated to determine whether this protein interacts directly with virus particles in the absence of other cell surface factors. The soluble protein comprised the extracellular region of the ALSV-A receptor fused to an antibody epitope tag and six histidine residues. Preincubating this protein with virus led to an efficient block to infection of avian cells by ALSV-A but had no effect on infection by ALSV-B, ALSV-C, or ALSV-D. Furthermore, an antibody directed against the introduced epitope tag immunoprecipitated ALSV-A particles bound to the soluble receptor. In contrast, other ALSV subgroups were not immunoprecipitated by this procedure. These data demonstrate that the cloned receptor interacts directly with ALSV-A and discriminates between different ALSV subgroups at the level of virus binding.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139053      PMCID: PMC236757     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

2.  Ecidence for linkage between genetic loci controlling response of fowl to subgroup A and subgroup C sarcoma viruses.

Authors:  L N Payne; P K Pani
Journal:  J Gen Virol       Date:  1971-11       Impact factor: 3.891

3.  Characteristics of two new avian tumor virus subgroups.

Authors:  R G Duff; P K Vogt
Journal:  Virology       Date:  1969-09       Impact factor: 3.616

4.  Reciprocal patterns of genetic resistance to avian tumor viruses in two lines of chickens.

Authors:  P K Vogt; R Ishizaki
Journal:  Virology       Date:  1965-08       Impact factor: 3.616

5.  Immunological relationships among envelope antigens of avian tumor viruses.

Authors:  R Ishizaki; P K Vogt
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

6.  An avian leukosis virus related to RSV(O): properties and evidence for helper activity.

Authors:  P K Vogt; R R Friis
Journal:  Virology       Date:  1971-01       Impact factor: 3.616

7.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

8.  A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor.

Authors:  P Bates; J A Young; H E Varmus
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

9.  Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail.

Authors:  C Moscovici; M G Moscovici; H Jimenez; M M Lai; M J Hayman; P K Vogt
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

10.  Two loci controlling genetic cellular resistance to avian leukosis-sarcoma viruses.

Authors:  L B Crittenden; H A Stone; R H Reamer; W Okazaki
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

View more
  28 in total

1.  Soluble receptor-induced retroviral infection of receptor-deficient cells.

Authors:  R Damico; P Bates
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 2.  Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.

Authors:  J Overbaugh; A D Miller; M V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2001-09       Impact factor: 11.056

3.  A fifteen-amino-acid TVB peptide serves as a minimal soluble receptor for subgroup B avian leukosis and sarcoma viruses.

Authors:  Daniel J Knauss; John A T Young
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity.

Authors:  L R Hoffman; I D Kuntz; J M White
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Efficient infection mediated by viral receptors incorporated into retroviral particles.

Authors:  J W Balliet; P Bates
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses.

Authors:  K Zingler; J A Young
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo.

Authors:  D Christiansen; P Devaux; B Réveil; A Evlashev; B Horvat; J Lamy; C Rabourdin-Combe; J H Cohen; D Gerlier
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

8.  Characterization of determinants for envelope binding and infection in tva, the subgroup A avian sarcoma and leukosis virus receptor.

Authors:  L Rong; K Gendron; B Strohl; R Shenoy; R J Wool-Lewis; P Bates
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

9.  Evolutionary pressure of a receptor competitor selects different subgroup a avian leukosis virus escape variants with altered receptor interactions.

Authors:  Deborah C Melder; V Shane Pankratz; Mark J Federspiel
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  The mature avian leukosis virus subgroup A envelope glycoprotein is metastable, and refolding induced by the synergistic effects of receptor binding and low pH is coupled to infection.

Authors:  Jason G Smith; Walther Mothes; Stephen C Blacklow; James M Cunningham
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.